CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Yao Y, Ng JF, Park WD, Samur M, Morelli E, Encinas Mayoral J, Chyra Z, Xu Y, Derebail S, Epstein C, Nabet B, Chesi M, Gray NS, Young RA, Kwiatkowski N, Mitsiades C, Anderson KC, Lin CY, Munshi NC, Fulciniti M.
Yao Y, et al. Among authors: ng jf.
Blood. 2023 Jun 8;141(23):2841-2852. doi: 10.1182/blood.2022018885.
Blood. 2023.
PMID: 36877894
Free PMC article.